A Combined Strategy of Thymoglobulin and CTLA4-Ig Cure Diabetes and Prevent Recurrence of Autoimmunity in NOD Mice

被引：0
|
作者：
Vergani, Andrea [1 ,3 ]
D'Addio, Francesca [1 ]
Petrelli, Alessandra [1 ,3 ]
Bassi, Roberto [1 ,3 ]
Williams, John [2 ]
Sayegh, Mohamed H. [1 ]
Fiorina, Paolo [1 ,3 ]
机构：
[1] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA
[2] Genzyme, Cambridge, England
[3] Hosp San Raffaele, I-20132 Milan, Italy
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：464 / 464
页数：1
相关论文
共 50 条
  • [41] IL-12p40-producing islet grafts prevent diabetes recurrence in NOD mice.
    Yasuda, H
    Nagata, M
    Arisawa, K
    Yoshida, R
    Fujihira, K
    Okamoto, N
    Moriyama, H
    Miki, M
    Tominaga, Y
    Hamada, H
    Yokono, K
    Kasuga, M
    DIABETES, 1997, 46 : 245 - 245
  • [42] Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
    Susanne M. Cabrera
    Samuel Engle
    Mary Kaldunski
    Shuang Jia
    Rhonda Geoffrey
    Pippa Simpson
    Aniko Szabo
    Cate Speake
    Carla J. Greenbaum
    Yi-Guang Chen
    Martin J. Hessner
    Diabetologia, 2018, 61 : 2356 - 2370
  • [43] Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
    Cabrera, Susanne M.
    Engle, Samuel
    Kaldunski, Mary
    Jia, Shuang
    Geoffrey, Rhonda
    Simpson, Pippa
    Szabo, Aniko
    Speake, Cate
    Greenbaum, Carla J.
    Chen, Yi-Guang
    Hessner, Martin J.
    DIABETOLOGIA, 2018, 61 (11) : 2356 - 2370
  • [44] Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model
    Oh, Annie L.
    Mahmud, Dolores
    Nicolini, Benedetta
    Mahmud, Nadim
    Bonetti, Elisa
    Patel, Pritesh R.
    Rondelli, Damiano
    BLOOD, 2013, 122 (21)
  • [45] Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism
    Li, S
    Thanikachalam, M
    Pang, M
    Carreno, M
    Aitouche, A
    Pham, SM
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (04) : 534 - 541
  • [46] Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4
    Ogawa, N
    List, JF
    Habener, JF
    Maki, T
    DIABETES, 2004, 53 (07) : 1700 - 1705
  • [47] Systemic administration of CTLA4-Ig inhibits rejection of liver allografts of Flt3-ligand-treated donor mice: Association with increased lymphocyte apoptosis.
    Li, W
    Lu, L
    Wang, Z
    Wang, L
    Thomson, AW
    Fung, JJ
    Qian, S
    TRANSPLANTATION, 2000, 69 (08) : S297 - S297
  • [48] Liver Restricted Expression of Canine Iduronidase Does Not Prevent a CTL Response in Adult MPS I Mice after Retroviral Vector-Mediated Gene Therapy, but Transient Immunomodulation with CTLA4-Ig Combined with Anti-CD4 or Anti-CD40 Ligand Does
    Ma, Xiucui
    Herati, Ramin
    Liu, Yuli
    Hennig, Anne K.
    Kovacs, Attila
    Ponder, Katherine P.
    MOLECULAR THERAPY, 2006, 13 : S378 - S379
  • [49] CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+regulatory T cell population
    Ko, Hyeok-Jae
    Cho, Mi-La
    Lee, Seon-Yeong
    Oh, Hye-Jwa
    Heo, Yu-Jung
    Moon, Young-Mee
    Kang, Chang-Min
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Park, Sung-Hwan
    Park, Kyung-Su
    Kim, Ho-Youn
    JOURNAL OF AUTOIMMUNITY, 2010, 34 (02) : 111 - 120
  • [50] Combination therapy with InsB9-23 peptide immunization and CTLA4-IgG does not reverse diabetes in NOD mice
    Schneider, Darius A.
    Sarikonda, Ghanashyam
    von Herrath, Matthias G.
    CLINICAL IMMUNOLOGY, 2012, 142 (03) : 402 - 403
12345